Seeking Alpha

Allergan (AGN -1.8%) stumbles midday as RBC says Caremark has removed Lumigan from its 2013...

Allergan (AGN -1.8%) stumbles midday as RBC says Caremark has removed Lumigan from its 2013 formulary coverage. RBC sees a $0.15 hit to AGN's 2013 EPS (company earned $0.74 in 2012 Q1).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs